163 related articles for article (PubMed ID: 22438421)
1. Pursuing the "Holy Grail".
Dickfeld T
Circ Cardiovasc Imaging; 2012 Mar; 5(2):167-70. PubMed ID: 22438421
[No Abstract] [Full Text] [Related]
2. Letter by Obeyesekere regarding article, "Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death".
Obeyesekere MN
Circ Cardiovasc Imaging; 2012 Jul; 5(4):e52; author reply e53. PubMed ID: 22811421
[No Abstract] [Full Text] [Related]
3. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
Wu KC; Gerstenblith G; Guallar E; Marine JE; Dalal D; Cheng A; Marbán E; Lima JA; Tomaselli GF; Weiss RG
Circ Cardiovasc Imaging; 2012 Mar; 5(2):178-86. PubMed ID: 22267750
[TBL] [Abstract][Full Text] [Related]
4. The role of implantable cardiac defibrillators in cardiac sarcoidosis: saviour or sinner?
Heck PM; Roberts PR
Europace; 2013 Mar; 15(3):309-10. PubMed ID: 23355135
[No Abstract] [Full Text] [Related]
5. Antitachycardia pacing therapy for the successful treatment of lead fracture.
Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
[No Abstract] [Full Text] [Related]
6. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
Cain ME
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
8. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
[TBL] [Abstract][Full Text] [Related]
9. ICD triple counting leading to a lethal inappropriate shock.
Korantzopoulos P; Manolis G; Manolis AG
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):231-233. PubMed ID: 31778244
[No Abstract] [Full Text] [Related]
10. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
[No Abstract] [Full Text] [Related]
11. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
12. Unusual substrate underlying Brugada syndrome and early repolarization syndrome revealed in unusual circadian and seasonal patterns.
Schwartz BG; Kloner RA; Cannom DS
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):764-5. PubMed ID: 22487225
[No Abstract] [Full Text] [Related]
13. [Primary and secondary prevention of sudden cardiac death].
Janion M; Sadowski M; Sielski J; Janion-Sadowska A
Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
[No Abstract] [Full Text] [Related]
14. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
15. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
16. Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
Thavikulwat AC; Tomson TT; Knight BP; Bonow RO; Choudhury L
J Cardiovasc Electrophysiol; 2016 Aug; 27(8):953-60. PubMed ID: 27138377
[TBL] [Abstract][Full Text] [Related]
17. CMR-determined scar volume: predictive for ventricular tachycardias?
van der Wall EE; Zeppenfeld K; Bax JJ; Siebelink HM; Schalij MJ
Int J Cardiovasc Imaging; 2011 Oct; 27(7):989-93. PubMed ID: 21061171
[TBL] [Abstract][Full Text] [Related]
18. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
19. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
[No Abstract] [Full Text] [Related]
20. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
